First AD

Second AD

CURE Expert Connections

Updates in Diagnosis, Treatment, and Management of Metastatic Uveal Melanoma

Expert Connections is a video series designed to help patients and their loved ones along their cancer care journey by offering information and expert advice from leaders in oncology care. Expert medical professionals share their knowledge and insights on an array of topics to allow for a better understanding of what to expect following a cancer diagnosis. Expert Connections hopes to bridge the gap between patients and oncology professionals to ensure no question is left unanswered.

Sunandana Chandra, MD, MS, discusses safety and efficacy data from the IMCgp100-202 trial on tebentafusp, and comments on the clinical implications of these data.

Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM

How Uveal Melanoma Differs from Cutaneous Melanoma

Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient

Historic and Current Treatment Options for mUM

Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM

An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources

Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy

Advice for Patients Living with Metastatic Uveal Melanoma

Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM

Latest News